Kairos Pharma Ltd. (KAPA), a clinical-stage biopharmaceutical company, will be presenting a talk on its investigational compound KROS 101, which is under preclinical development. KROS 101 targets the GITR ligand and enables T cells to increase in numbers and kill cancer cells more effectively.
The following are some of the other biotech stocks making big moves in premarket trading today.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com